Catherine Coombs, MD, on BTK Inhibitors in CLL

Catherine Coombs, MD, of the University of California, Irvine, discusses Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia (CLL) at the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting.